MS4322 is a selective protein arginine methyltransferase 5 degrader with antitumor effects in cervical cancer cells.
Saved in:
| Title: | MS4322 is a selective protein arginine methyltransferase 5 degrader with antitumor effects in cervical cancer cells. |
|---|---|
| Authors: | Luo R; Department of Obstetrics and Gynecology, Linyi People's Hospital, Shandong Second Medical University, Linyi, Shandong 276000, P.R. China., Chen J; Department of Critical Care Medicine, Yulin Hospital of the First Affiliated Hospital of Xi'an Jiaotong University, Yulin, Shanxi 719000, P.R. China., Chen Z; Department of Obstetrics and Gynecology, Linyi People's Hospital, Shandong Second Medical University, Linyi, Shandong 276000, P.R. China., Wang S; Department of Obstetrics and Gynecology, Linyi People's Hospital, Shandong Second Medical University, Linyi, Shandong 276000, P.R. China., Liu T; Department of Obstetrics and Gynecology, Linyi People's Hospital, Shandong Second Medical University, Linyi, Shandong 276000, P.R. China., Xu Y; Department of Reproductive Medicine, Linyi People's Hospital, Shandong Second Medical University, Linyi, Shandong 276000, P.R. China. |
| Source: | Oncology reports [Oncol Rep] 2026 May; Vol. 55 (5). Date of Electronic Publication: 2026 Mar 27. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: D.A. Spandidos Country of Publication: Greece NLM ID: 9422756 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1791-2431 (Electronic) Linking ISSN: 1021335X NLM ISO Abbreviation: Oncol Rep Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
